|
1
|
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma.
|
Cancer Cell
|
2011
|
2.78
|
|
2
|
Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma.
|
Cancer Res
|
2010
|
2.61
|
|
3
|
Regulation of endocytosis via the oxygen-sensing pathway.
|
Nat Med
|
2009
|
2.00
|
|
4
|
Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
|
Am J Surg Pathol
|
2008
|
1.70
|
|
5
|
MicroRNA profiling of human kidney cancer subtypes.
|
Int J Oncol
|
2009
|
1.68
|
|
6
|
A molecular classification of papillary renal cell carcinoma.
|
Cancer Res
|
2005
|
1.60
|
|
7
|
Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma.
|
Carcinogenesis
|
2005
|
1.59
|
|
8
|
Identification of a lysosomal pathway that modulates glucocorticoid signaling and the inflammatory response.
|
Sci Signal
|
2011
|
1.58
|
|
9
|
The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development.
|
PLoS One
|
2009
|
1.47
|
|
10
|
Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
|
Oncogene
|
2003
|
1.42
|
|
11
|
Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer.
|
Proc Natl Acad Sci U S A
|
2009
|
1.42
|
|
12
|
Genetic and structural variation in the gastric cancer kinome revealed through targeted deep sequencing.
|
Cancer Res
|
2010
|
1.41
|
|
13
|
The E2F3-Oncomir-1 axis is activated in Wilms' tumor.
|
Cancer Res
|
2008
|
1.33
|
|
14
|
Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data.
|
Genome Biol
|
2002
|
1.29
|
|
15
|
CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma.
|
Cancer Res
|
2013
|
1.23
|
|
16
|
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response.
|
PLoS Genet
|
2008
|
1.20
|
|
17
|
Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
|
BJU Int
|
2009
|
1.18
|
|
18
|
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.
|
Cancer Res
|
2009
|
1.15
|
|
19
|
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.
|
BMC Cancer
|
2010
|
1.08
|
|
20
|
Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
|
Cancer Res
|
2002
|
1.06
|
|
21
|
Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.
|
BMC Med Genomics
|
2010
|
1.06
|
|
22
|
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.
|
Proc Natl Acad Sci U S A
|
2011
|
1.05
|
|
23
|
Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladder.
|
BMC Med Genomics
|
2010
|
1.03
|
|
24
|
Evaluation of sex-specific gene expression in archived dried blood spots (DBS).
|
Int J Mol Sci
|
2012
|
0.92
|
|
25
|
Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.
|
Cancer Res
|
2011
|
0.90
|
|
26
|
Gene expression profiling of renal cell carcinoma.
|
Clin Cancer Res
|
2004
|
0.89
|
|
27
|
Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma.
|
Cancer Res
|
2012
|
0.88
|
|
28
|
Genome-wide matching of genes to cellular roles using guilt-by-association models derived from single sample analysis.
|
BMC Res Notes
|
2012
|
0.88
|
|
29
|
Gene expression profiling of early- and late-relapse nonseminomatous germ cell tumor and primitive neuroectodermal tumor of the testis.
|
Clin Cancer Res
|
2004
|
0.88
|
|
30
|
MK-STYX, a catalytically inactive phosphatase regulating mitochondrially dependent apoptosis.
|
Mol Cell Biol
|
2011
|
0.86
|
|
31
|
Diminished transcription of chromosome arm 4q is inversely related to local spreading of hepatocellular carcinoma.
|
Genes Chromosomes Cancer
|
2004
|
0.86
|
|
32
|
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma.
|
Am J Pathol
|
2011
|
0.84
|
|
33
|
MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells.
|
PLoS One
|
2011
|
0.84
|
|
34
|
Fumarate hydratase inactivation in renal tumors: HIF1α, NRF2, and "cryptic targets" of transcription factors.
|
Chin J Cancer
|
2012
|
0.84
|
|
35
|
Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma.
|
Mol Cancer Ther
|
2013
|
0.83
|
|
36
|
CIT: identification of differentially expressed clusters of genes from microarray data.
|
Bioinformatics
|
2002
|
0.81
|
|
37
|
Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation.
|
PLoS One
|
2012
|
0.79
|
|
38
|
A comparison study reveals important features of agreement and disagreement between summarized DNA and RNA data obtained from renal cell carcinoma.
|
Mutat Res
|
2008
|
0.79
|
|
39
|
Experimental approaches to microarray analysis of tumor samples.
|
Biochem Mol Biol Educ
|
2008
|
0.75
|